Abstract
Polysaccharide is a kind of biological material, which has good biocompatibility, non-toxicity, and nonimmunogenicity. So, the polysaccharide has been widely applied in drug delivery system. The chemical modifications of chitosan and hyaluronic acid as drug carriers were summarized herein.
Keywords: Chemical modifications, Chitosan, drug carriers, hyaluronic acid.
Graphical Abstract
Current Organic Synthesis
Title:Chemical Modifications of Two Polysaccharides as Drug Carriers
Volume: 12 Issue: 3
Author(s): Gangliang Huang, Hualiang Huang, Qilin Tang and Xinya Mei
Affiliation:
Keywords: Chemical modifications, Chitosan, drug carriers, hyaluronic acid.
Abstract: Polysaccharide is a kind of biological material, which has good biocompatibility, non-toxicity, and nonimmunogenicity. So, the polysaccharide has been widely applied in drug delivery system. The chemical modifications of chitosan and hyaluronic acid as drug carriers were summarized herein.
Export Options
About this article
Cite this article as:
Huang Gangliang, Huang Hualiang, Tang Qilin and Mei Xinya, Chemical Modifications of Two Polysaccharides as Drug Carriers, Current Organic Synthesis 2015; 12 (3) . https://dx.doi.org/10.2174/1570179412666150218201607
DOI https://dx.doi.org/10.2174/1570179412666150218201607 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Peroxisome Proliferator-Activated Receptor-γ and Its Ligands in the Treatment of Tumors in the Nervous System
Current Stem Cell Research & Therapy Current Research on Opioid Receptor Function
Current Drug Targets Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade
Current Medicinal Chemistry Targeting Apoptosis Pathways in Cancer Therapy
Current Cancer Drug Targets Epigenetic and Disease Targets by Polyphenols
Current Pharmaceutical Design Self-Assembled Micelles of Amphiphilic PEGylated Drugs for Cancer Treatment
Current Drug Targets Cancer Cell Reprogramming: Stem Cell Differentiation Stage Factors and An Agent Based Model to Optimize Cancer Treatment
Current Pharmaceutical Biotechnology Synthetic and Biological Vesicular Nano-Carriers Designed for Gene Delivery
Current Pharmaceutical Design Oxidative Stress and Cancer: The Role of Nrf2
Current Cancer Drug Targets Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme
Current Pharmaceutical Design Differences in Phosphorylated Histone H2AX Foci Formation and Removal of Cells Exposed to Low and High Linear Energy Transfer Radiation
Current Genomics Amyloid-Beta Peptide 1-42 Causes Microtubule Deregulation through N-methyl-D-aspartate Receptors in Mature Hippocampal Cultures
Current Alzheimer Research Studies on Non-synonymous Polymorphisms Altering Human DNA Topoisomerase II-Alpha Interaction with Amsacrine and Mitoxantrone: An <i>In Silico</i> Approach
Current Cancer Drug Targets Inorganic Nanoparticles for Enhanced Photodynamic Cancer Therapy
Current Drug Discovery Technologies Pharmacogenetics of Non-small Cell Lung Cancer (NSCLC): Time to "Work it Out"?
Current Pharmaceutical Design The “Big Five” Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein
Current Medicinal Chemistry The Therapeutic Potential of miR-7 in Cancers
Mini-Reviews in Medicinal Chemistry Glioblastoma Stem-Like Cells – Isolation, Biology and Mechanisms of Chemotherapy Resistance
Current Signal Transduction Therapy Editorial (Thematic Issue: GPCR-Targeted Drug Development)
Current Drug Targets Recent Approaches to Improve the Antitumor Efficacy of Temozolomide
Current Medicinal Chemistry